2006
DOI: 10.1016/j.pharmthera.2005.12.001
|View full text |Cite
|
Sign up to set email alerts
|

What has been learnt from study of dopamine receptors in Parkinson's disease?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
83
1
1

Year Published

2007
2007
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 98 publications
(87 citation statements)
references
References 158 publications
2
83
1
1
Order By: Relevance
“…In progressively MPTPlesioned monkeys, Drd2 receptor binding is initially decreased, followed by later upregulation (Bezard et al, 2001). The biphasic pattern of Drd2 expression in that report and in our study may reflect paucity of presynaptic Drd2 receptors (Hurley and Jenner 2006) due to failed development of nigrostriatal projections (Nunes et al, 2003) followed by postsynaptic upregulation.…”
Section: Discussionsupporting
confidence: 59%
See 4 more Smart Citations
“…In progressively MPTPlesioned monkeys, Drd2 receptor binding is initially decreased, followed by later upregulation (Bezard et al, 2001). The biphasic pattern of Drd2 expression in that report and in our study may reflect paucity of presynaptic Drd2 receptors (Hurley and Jenner 2006) due to failed development of nigrostriatal projections (Nunes et al, 2003) followed by postsynaptic upregulation.…”
Section: Discussionsupporting
confidence: 59%
“…In animals, declining Drd3 receptors are associated with motor dysfunction, while increasing Drd3 levels accompany levodopa therapy (Quik et al, 2000) or functional recovery (Wade et al, 2001). Either increased or decreased D3 levels are reported in human patients (Hurley and Jenner 2006). Declining striatal expression of Drd1a and Drd4 in our ak mice are difficult to interpret in the light of published findings.…”
Section: Discussionmentioning
confidence: 76%
See 3 more Smart Citations